PL111183B1 - Method of obtaining a cephaloxine preparation - Google Patents

Method of obtaining a cephaloxine preparation Download PDF

Info

Publication number
PL111183B1
PL111183B1 PL1977198058A PL19805877A PL111183B1 PL 111183 B1 PL111183 B1 PL 111183B1 PL 1977198058 A PL1977198058 A PL 1977198058A PL 19805877 A PL19805877 A PL 19805877A PL 111183 B1 PL111183 B1 PL 111183B1
Authority
PL
Poland
Prior art keywords
cephalexin
preparation
hours
time
curve
Prior art date
Application number
PL1977198058A
Other languages
English (en)
Polish (pl)
Other versions
PL198058A1 (pl
Inventor
Hideyuki Osaka Jp Maekawa
Yasushi Nishinomiya Hyogo Jp Takagishi
Hiroshi Kobe Hyogo Jp Kato
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of PL198058A1 publication Critical patent/PL198058A1/xx
Publication of PL111183B1 publication Critical patent/PL111183B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
PL1977198058A 1976-05-13 1977-05-12 Method of obtaining a cephaloxine preparation PL111183B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5492576A JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations

Publications (2)

Publication Number Publication Date
PL198058A1 PL198058A1 (pl) 1979-03-26
PL111183B1 true PL111183B1 (en) 1980-08-30

Family

ID=12984185

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1977198058A PL111183B1 (en) 1976-05-13 1977-05-12 Method of obtaining a cephaloxine preparation

Country Status (27)

Country Link
JP (1) JPS52139713A (enrdf_load_stackoverflow)
AR (1) AR224494A1 (enrdf_load_stackoverflow)
AT (1) AT351159B (enrdf_load_stackoverflow)
AU (1) AU508793B2 (enrdf_load_stackoverflow)
BE (1) BE854640A (enrdf_load_stackoverflow)
CA (1) CA1085296A (enrdf_load_stackoverflow)
CS (1) CS208196B2 (enrdf_load_stackoverflow)
DD (1) DD132232A5 (enrdf_load_stackoverflow)
DE (1) DE2721785A1 (enrdf_load_stackoverflow)
DK (1) DK208077A (enrdf_load_stackoverflow)
ES (1) ES458710A1 (enrdf_load_stackoverflow)
FI (1) FI771491A7 (enrdf_load_stackoverflow)
FR (1) FR2350836A1 (enrdf_load_stackoverflow)
GB (1) GB1543543A (enrdf_load_stackoverflow)
GR (1) GR68895B (enrdf_load_stackoverflow)
HU (1) HU184196B (enrdf_load_stackoverflow)
IE (1) IE45415B1 (enrdf_load_stackoverflow)
IL (1) IL52075A (enrdf_load_stackoverflow)
MX (1) MX5976E (enrdf_load_stackoverflow)
NL (1) NL7704879A (enrdf_load_stackoverflow)
NZ (1) NZ183927A (enrdf_load_stackoverflow)
PL (1) PL111183B1 (enrdf_load_stackoverflow)
PT (1) PT66514B (enrdf_load_stackoverflow)
RO (1) RO72935A (enrdf_load_stackoverflow)
SE (1) SE426780B (enrdf_load_stackoverflow)
SU (1) SU1218919A3 (enrdf_load_stackoverflow)
ZA (1) ZA772757B (enrdf_load_stackoverflow)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545601A (en) * 1978-09-26 1980-03-31 Toyo Jozo Co Ltd Long-acting cephalexin and its preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS5883106U (ja) * 1981-11-30 1983-06-06 松下電工株式会社 電磁石装置に於けるオイルダツシユポツト
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
FR2577800B1 (fr) * 1985-02-22 1990-09-07 Grimberg Georges Medicament sous forme galenique gastro-resistante
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
WO2006110807A1 (en) * 2005-04-12 2006-10-19 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
CN114617855A (zh) * 2020-12-14 2022-06-14 江苏贝佳制药有限公司 头孢氨苄胶囊的制备方法

Also Published As

Publication number Publication date
CA1085296A (en) 1980-09-09
SE426780B (sv) 1983-02-14
DD132232A5 (de) 1978-09-13
BE854640A (fr) 1977-09-01
IE45415L (en) 1977-11-13
IL52075A (en) 1980-06-30
PT66514A (en) 1977-06-01
FR2350836B1 (enrdf_load_stackoverflow) 1981-02-06
JPS5547611B2 (enrdf_load_stackoverflow) 1980-12-01
AT351159B (de) 1979-07-10
FR2350836A1 (fr) 1977-12-09
RO72935A (ro) 1982-07-06
HU184196B (en) 1984-07-30
JPS52139713A (en) 1977-11-21
AU508793B2 (en) 1980-04-03
ATA341877A (de) 1978-12-15
ZA772757B (en) 1978-04-26
NL7704879A (nl) 1977-11-15
AR224494A1 (es) 1981-12-15
DE2721785A1 (de) 1977-11-24
IE45415B1 (en) 1982-08-25
ES458710A1 (es) 1978-03-01
NZ183927A (en) 1980-02-21
DK208077A (da) 1977-11-14
FI771491A7 (enrdf_load_stackoverflow) 1977-11-14
PL198058A1 (pl) 1979-03-26
DE2721785C2 (enrdf_load_stackoverflow) 1989-03-16
AU2507877A (en) 1978-11-16
GB1543543A (en) 1979-04-04
PT66514B (en) 1978-10-16
GR68895B (enrdf_load_stackoverflow) 1982-03-15
IL52075A0 (en) 1977-07-31
SE7705502L (sv) 1977-11-14
SU1218919A3 (ru) 1986-03-15
CS208196B2 (en) 1981-08-31
MX5976E (es) 1984-09-12

Similar Documents

Publication Publication Date Title
EP1940361B1 (en) Pharmaceutical dosage forms having immediate release and/or controlled release properties
US4250166A (en) Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
JP6530772B2 (ja) アンチセンス組成物およびその作製および使用
CA2104686C (en) Delayed release oral dosage forms for treatment of intestinal disorders
KR100270491B1 (ko) 약제 송출 시스템 및 그의 제조방법
US8968777B2 (en) Tranexamic acid formulations with reduced adverse effects
CA2268868C (en) Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
JPH09500617A (ja) 腸管の異常ｐＨ値の調整及び腸疾患の処置のために使用する組成物
PL111183B1 (en) Method of obtaining a cephaloxine preparation
SK279358B6 (sk) Farmaceutický aplikačný prostriedok a spôsob jeho
AU731693B2 (en) Drug formulation having controlled release of active compound
AU702934B2 (en) Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
US4976949A (en) Controlled release dosage form
US20240082168A1 (en) Controlled drug release formulation
CA2672686A1 (en) Pharmaceutical formulations
Kadiyala et al. The study of marketed and experimental formulation approaches enabling site-specific delivery of mesalamine in patients with inflammatory bowel disease
WO2002066004A1 (fr) Compositions a liberation controlee de medicament
AU2022392482A1 (en) Controlled release formulations of flavoxate and process for preparation thereof
MX2008004282A (en) Pharmaceutical dosage forms having immediate release and/orcontrolled release properties